Thrombophilia among Chinese women with venous thromboembolism during pregnancy

Gynecol Obstet Invest. 2012;73(3):183-8. doi: 10.1159/000331648. Epub 2012 Mar 6.

Abstract

Aims: To assess the prevalence of thrombophilia among Chinese women with venous thromboembolism (VTE) developed during pregnancy.

Methods: Based on information from a tertiary teaching unit, all recorded cases of deep vein thrombosis (DVT) and pulmonary embolism (PE) during pregnancy diagnosed between 1997 and 2005, were assessed for prevalence of thrombophilia. Fifty-five healthy women, who had at least one normal pregnancy but without any previous history of VTE, were recruited as controls.

Results: A total of 44 subjects completed thrombophilia screening, of whom 5 (11%) were confirmed to have thrombophilia [protein C (PC) deficiency (2), protein S (PS) deficiency (1), combined PC & PS deficiency (1) and antithrombin III deficiency (1)]. Homozygous 5,10-methylenetetrahydrofolate reductase (C677T) gene mutation was found in 6 (14%) subjects but not in the controls. There was no antiphospholipid syndrome, activated PC resistance, factor V Leiden or prothrombin gene mutations.

Conclusion: In the Chinese population, PS and PC deficiencies are common thrombophilia for VTE during pregnancy and thrombophilia screening should be recommended in all pregnant women who suffer from VTE.

MeSH terms

  • Activated Protein C Resistance / epidemiology
  • Adult
  • Antithrombin III Deficiency / epidemiology
  • Asian People / ethnology
  • Case-Control Studies
  • Cohort Studies
  • DNA Primers / chemistry
  • Factor V / genetics
  • Female
  • Hong Kong / epidemiology
  • Humans
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics
  • Mutation
  • Pregnancy
  • Pregnancy Complications, Hematologic*
  • Prevalence
  • Prospective Studies
  • Protein C Deficiency / epidemiology
  • Protein S Deficiency / epidemiology
  • Prothrombin / genetics
  • Pulmonary Embolism / epidemiology
  • Thrombophilia / epidemiology*
  • Venous Thrombosis / epidemiology*

Substances

  • DNA Primers
  • factor V Leiden
  • Factor V
  • Prothrombin
  • MTHFR protein, human
  • Methylenetetrahydrofolate Reductase (NADPH2)